Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

BACKGROUND: The benefit of sulfonylureas (SUs) to patients with type 2 diabetes mellitus receiving long-term insulin treatment is unclear. This study evaluated glycemic control and beta-cell function after SU withdrawal in these patients. METHODS: In this 8-week randomized controlled study, patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab Syndr Obes
Main Authors: Srivanichakorn, Weerachai, Sriwijitkamol, Apiradee, Kongchoo, Aroon, Sriussadaporn, Sutin, Plengvidhya, Nattachet, Lertwattanarak, Raweewan, Vannasaeng, Sathit, Thongtang, Nuntakorn
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354396/
https://ncbi.nlm.nih.gov/pubmed/25767401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S78008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados